Data from: Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness

  • Lance S. Eberson (Creator)
  • Pablo Sanchez (Creator)
  • Beenish A. Majeed (Creator)
  • Supannikar Tawinwung (Creator)
  • Timothy W Secomb (Creator)
  • Douglas F. Larson (Creator)
  • Pablo A. Sanchez (Creator)
  • Supannikar Tawinwung (Creator)



It is well accepted that angiotensin II (Ang II) induces altered vascular stiffness through responses including both structural and material remodeling. Concurrent with remodeling is the induction of the enzyme lysyl oxidase (LOX) through which ECM proteins are cross-linked. The study objective was to determine the effect of LOX mediated cross-linking on vascular mechanical properties. Three-month old mice were chronically treated with Ang II with or without the LOX blocker, β -aminopropionitrile (BAPN), for 14 days. Pulse wave velocity (PWV) from Doppler measurements of the aortic flow wave was used to quantify in vivo vascular stiffness in terms of an effective Young’s modulus. The increase in effective Young’s modulus with Ang II administration was abolished with the addition of BAPN, suggesting that the material properties are a major controlling element in vascular stiffness. BAPN inhibited the Ang II induced collagen cross-link formation by 2-fold and PWV by 44% (P
Date made availableDec 18 2015

Cite this